- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.
The Food and Drug Administration (FDA) has granted dual 510(k) clearances for the pocket-sized Kardia 12L electrocardiography (ECG) system and KAI 12L artificial intelligence (AI) technology, which may bolster the detection of life-threating cardiac conditions with a reduced leadset.
Trained on more than 175 million ECGs, the deep neural network algorithms with KAI 12L may facilitate the diagnosis of 35 cardiac determinations, including common forms of cardiac ischemia and acute myocardial infarction, according to AliveCor, the developer of the technology.
Dual FDA clearances for the pocket-sized Kardia 12L ECG System (shown above) and the KAI 12L AI technology, trained on more than 175 million ECGs, may bolster the detection of cardiac conditions and facilitate use of the technology in resource-challenged health-care facilities, according to AliveCor, the developer of the modalities. (Photo courtesy of AliveCor.)
"Not only is it the first FDA-cleared AI that can detect a heart attack on a reduced leadset, but it also returns determinations for our broadest range of conditions yet," said Priya Abani, the CEO of AliveCor. "Paired with our pocket-sized Kardia 12L ECG System, this offering is poised to disrupt traditional care pathways and represents a leap forward in cardiac care."
In comparison to standard 12-lead ECG devices, the pocket-sized Kardia 12L ECG system enables clinicians to capture eight quality diagnostic bandwidth leads with five electrodes and a single cable. AliveCor added that the portability of the battery-operated, 0.3-lb. device may expand access to the technology for a variety of health-care facilities including resource-challenged centers or rural medical facilities.
AMA Issues 2025 Category III CPT Code for the ECG-Based AI Platform EchoGo Heart Failure
July 2nd 2024The EchoGo Heart Failure platform is reportedly the only AI-powered technology to receive a CPT reimbursement code for echocardiography detection of heart failure with preserved ejection fraction.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Adjunctive AI Leads to 16 Percent Increase in CT Sensitivity for Incidental Pulmonary Embolism
June 20th 2024Artificial intelligence facilitated a 96.2 percent sensitivity rate for incidental pulmonary embolism (IPE) on contrast-enhanced CT chest or abdomen exams, according to new prospective research involving over 4,300 patients.
